GlassScriptPhysician profile
Jami Grace Howell
NPI 1578234365
$6,850.07
in general payments reported to CMS, 2019-2025
31 companies · $1,086 in 2025
The $1,086 reported for 2025 was more than what 84% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $41.60 · 2022: $2,924 · 2023: $1,922 · 2024: $876 · 2025: $1,086.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,226 · Travel and Lodging: $458 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,226.47 |
| Travel and Lodging | $457.61 |
| Education | $200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $2,165.70 | 2022-2024 | Axonics |
| Boston Scientific Corporation | $734.87 | 2023-2025 | Ams 700 Cxr Rte Kit, Axonics, Ams 700 |
| Janssen Biotech, INC. | $616.77 | 2021-2025 | Erleada, Akeega, Balversa |
| Dendreon Pharmaceuticals LLC | $532.42 | 2022-2025 | Provenge |
| Myriad Genetic Laboratories, INC. | $446.52 | 2022-2025 | Myrisk, Prolaris |
| Teleflex LLC | $280.36 | 2024-2025 | Urolift |
| Sumitomo Pharma America, INC. | $276.51 | 2023-2025 | Gemtesa, Orgovyx |
| Bayer Healthcare Pharmaceuticals INC. | $265.23 | 2021-2025 | |
| Astellas Pharma US INC | $242.22 | 2023-2024 | Xtandi, Myrbetriq |
| C. R. Bard, INC. & Subsidiaries | $182.69 | 2023 | Bard Urinary Drainage Bag |
| Pfizer INC. | $137.01 | 2023-2025 | |
| Myovant Sciences INC. | $110.64 | 2022 | |
| Procept Biorobotics Corporation | $92.10 | 2024-2025 | Aquabeam System |
| Abbvie INC. | $87.57 | 2022-2025 | |
| Endo USA, INC. | $87.03 | 2024-2025 | Xiaflex |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rochester Medical Corporation | $80.15 | 2022 | |
| Tolmar, INC. | $59.22 | 2024-2025 | Eligard, Jatenzo |
| Agiliti Health, INC. | $55.19 | 2025 | Koelis Trinity Mri/US Fusion, Sonablate Hifu |
| Endo Pharmaceuticals INC. | $49.33 | 2022-2024 | Xiaflex |
| Blue Earth Diagnostics | $48.37 | 2022-2023 | |
| Medtronic, INC. | $46.83 | 2023 | Interstim |
| Verity Pharmaceuticals INC. | $39.02 | 2023 | Trelstar |
| Pacira Pharmaceuticals Incorporated | $31.40 | 2023 | Iovera, Zilretta, Exparel |
| Kowa Pharmaceuticals America, INC. | $30.34 | 2023 | Seglentis |
| Urovant Sciences INC | $30.21 | 2022 | |
| Antares Pharma, INC. | $29.02 | 2022-2025 | Xyosted |
| Amgen INC. | $22.13 | 2022 | |
| Halozyme INC | $20.24 | 2023 | |
| Urogen Pharma, INC. | $18.58 | 2025 | |
| Olympus America INC. | $17.09 | 2025 | Itind System |
| Merck Sharp & Dohme LLC | $15.31 | 2024 | Keytruda |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jami Howell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.